Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy
Clinical trial NCT06391775 · TERMINATED
Trial details
- NCT number
- NCT06391775
- Sponsor
- Genmab
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-14
- Primary completion
- 2025-11-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.